Symbio Pharmaceuticals Ltd operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Symbio Pharmaceuticals Ltd with three other
companies in this sector in Japan:
GNI Group Limited
sales of 2.65 billion Japanese Yen [US$24.84 million]
Medical Data Vision Co Ltd
(3.23 billion Japanese Yen [US$30.26 million]
Trans Genic Inc
(2.30 billion Japanese Yen [US$21.60 million]
of which 50%
was CRO Business).
Symbio Pharmaceuticals Ltd reported sales of ¥3.44 billion (US$32.31 million)
December of 2017.
increase of 45.4%
versus 2016, when the company's sales were ¥2.37 billion.